US to investigate Germany's proposed drug spending reforms

The United States government is reportedly preparing to investigate proposed drug spending reforms in Germany, a move that underscores the high stakes of international pharmaceutical pricing policy. These proposed German reforms aim to tighten controls on drug expenditures, potentially impacting the profitability and market entry strategies of global pharmaceutical companies. For the industry, this investigation represents a significant moment where national healthcare policy intersects with international trade relations and the protection of intellectual property value.